Recent regulatory filings submitted to the United States Securities and Exchange Commission outline a planned securities transaction involving NXP Semiconductors N.V. The documentation centers on a proposed stock disposition governed under the standard guidelines of Rule 144.
The filing specifically highlights corporate officer Andrew J. Micallef as the individual initiating the upcoming market activity. Such transparency measures are vital for tracking executive portfolio adjustments across major multinational technology enterprises.
Understanding the Transaction Mechanics
The official disclosure details an explicit intent to unload 1,000 shares of common stock through brokerage firm Morgan Stanley Smith Barney LLC. Based on current valuations, the aggregate market value for the targeted shares rests at $226,040. Similar analytical precision is often required when evaluating complex optics articles and financial disclosures.
Execution of this planned transaction is designated to take place directly on the NASDAQ exchange. The targeted execution window was scheduled for September 15, 2026, reflecting standard corporate compliance protocols.
Acquisition Background and Compliance
The securities slated for the transaction originated as direct grants of restricted stock from the issuer on two distinct dates. Specifically, records show an acquisition of 55 shares on November 2, 2024, followed by another 945 shares on November 7, 2024.
Furthermore, the regulatory paperwork confirmed that no other sales of the issuer’s securities occurred for this account throughout the preceding three months. The filer successfully adopted an associated Rule 10b5-1 trading plan back on August 1, 2025, while formally confirming a complete lack of undisclosed material adverse information.
Here is the source article for this story: Form 144 NXP SEMICONDUCTORS N.V. For: 15 November
